Summary
In the present study, we describe the isolation and characterization of a cDNA clone designated B6F1.3, that appears to ‘activate’ the hyaluronan-binding capacity of CD44 upon transfection into the murine fibroblastoid cell line MOP8. Sequence analysis indicates that the putative regulatory molecule encoded by this clone is identical to the murine interleukin-2 receptor γ chain (mIL-2Rγ), a recently described type 1 transmembrane protein that constitutes an integral component of the cell surface receptors that bind a number of cytokines including IL-2, IL-4, IL-7, IL-9, IL-15 and perhaps also IL-13. Mutations in this molecule have been shown to be responsible for X-linked severe combined immunodeficiency (XSCID) in humans. With the exception of bone marrow, the mIL-2Rγ chain was found to be expressed at high levels on all hemopoietic cell lines and tissue types examined. Non-hemopoietic tissues are generally negative. FACS analysis and Western blot analysis indicated respectively that B6F1.3 does not mediate its effects by upregulating the expression of CD44 or by altering the alternative splicing of the molecule. Removal of the cytoplasmic tail of the mIL-2Rγ chain, including a Src homology region 2 (SH2) subdomain, abolished its ability to enhance CD44-mediated binding to hyaluronan suggesting the involvement of signal transduction events triggered via the cytoplasmic domain in the ‘activation’ process. Determining whether activating molecules such as B6F1.3 are co-expressed within tumor cells may help improve the potential value of CD44 as a diagnostic marker of metastatic disease.
Similar content being viewed by others
References
Herrlich P, Zoller M, Pals ST, Ponta H: CD44 splice varients: metastases meet lymphocytes. Immunol Today 14: 395–399, 1993
Matsumura Y, Tarin D: Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 340: 1053–1058, 1992
Jiang WG, Puntis MC, Hallett MB: Molecular and cellular basis of cancer invasion and metastasis: implications for treatment. Br J Surg 81: 1576–1590, 1994
Price JE: Analyzing the metastatic phenotype. J Cell Biochem 56: 16–22, 1994
Culty M, Miyake K, Kincade PW, Sikorski E, Butcher EC, Underhill CB: The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J Cell Biol 111: 2765–2774, 1990
Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B: CD44 is the principle cell surface receptor for hyaluronate. Cell 61: 1303–1313, 1990
Miyake K, Underhill CB, Lesley J, Kincade PW: Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 172: 69–75, 1990
Lesley J, Schulte R, Hyman R: Binding of hyaluronic acid to lymphoid cell lines is inhibited by monoclonal antibodies against Pgp-1. Exp Cell Res 187: 224–233, 1990
Yang B, Yang BL, Savani RC, Turley EA: Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. EMBO J 13: 286–296, 1994
Peach RJ, Hollenbaugh D, Stamenkovic I, Aruffo A: Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J Cell Biol 122: 257–264, 1993
Hyman R, Lesley J, Schulte R: Somatic cell mutants distinguish CD44 expression and hyaluronic acid binding. Immunogenetics 33: 392–395, 1991
Mackay CR, Imhof BA: Cell adhesion in the immune system. Immunology Today 14: 99–102, 1993
Stoolman LM: Adhesion molecules involved in leukocyte recruitment and lymphocyte recirculation. Chest 103: 79S-86S, 1993
Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301–314, 1994
van der Merwe PA, Barclay AN: Transient intercellular adhesion: the importance of weak protein-protein interactions. TIBS 19: 354–358, 1994
Pullman WE, Bodmer WF: Cloning and characterization of a gene that regulates cell adhesion. Nature 356: 529–532, 1992
Greenberger TS, Sakakeeny MA, Humphries RK, Eaves CJ, Eckner RJ: Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines. Proc Natl Acad Sci USA 80: 2931–2935, 1983
Muller WJ, Naujokas MA, Hassell JA: Isolation of large T antigen-producing mouse cell lines capable of supporting replication of polyomavirus-plasmid recombinants. Mol Cell Biol 4: 2406–2412, 1984
Droll A, Dougherty ST, Chiu RK, Dirks JF, McBride WH, Cooper DL, Dougherty GJ: Adhesive interactions between alternatively spliced CD44 isoforms. J Biol Chem (in press)
Suit HD, Kastellan A: Immunologic status of host and response of a methylcholanthrene-induced fibrosarcoma to local irradiation. Cancer 26: 232–238, 1970
McBride WH: Phenotype and functions of intratumoral macrophages. Biochem Biophys Acta Rev Cancer 865: 27–41, 1986
Miyake K, Medina KL, Hayashi SI, Ono S, Hamaoka T, Kincade PW: Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J Exp Med 171: 477–488, 1990
Seed B: An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2. Nature 329: 840–842, 1987
Seed B, Aruffo A: Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by rapid immunoselection procedure. Proc Natl Acad Sci USA 84: 8573–8577, 1987
Gubler U, Hoffman BJ: A simple and very efficient method for generating cDNA libraries. Gene 25: 263–269, 1983
Kay R, Humphries RK: New vectors and procedures for isolating cDNAs encoding cell surface proteins by expression in COS cells. Methods Mol Cell Biol 2: 254–265, 1991
Sandri-Goldin RM, Goldin AL, Levine M, Glorioso J: High-efficiency transfer of DNA into eukaryotic cells by protoplast fusion. Methods Enzymol 101: 402–411, 1983
Dougherty GJ, Lansdorp PM, Cooper DL, Humphries RK: Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte ‘homing’ receptor expressed by hemopoietic cells. J Exp Med 174: 1–5, 1991
Dougherty GJ, Kay RJ, Humphries RK: Molecular cloning of 114/A10, a cell surface antigen containing highly conserved repeated elements, which is expressed by murine hemopoietic progenitor cells and interleukin-3-dependent cell lines. J Biol Chem 264: 6509–6514, 1989
Hattori M, Sakaki Y: Dideoxy sequencing method using denatured plasmid templates. Anal Biochem 152: 232–238, 1986
Haynes BF, Telen MJ, Hale LP, Denning SM: CD44-A molecule involved in leukocyte adherence and T-cell activation. Immunol Today 10: 423–428, 1989
Haynes BF, Liao H-X, Patton KL: The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. Cancer Cells 3: 347–350, 1991
Lesley J, Hyman R, Kincade PW: CD44 and its interaction with the cytoskeleton. Adv Immunol 54: 271–335, 1993
Lesley J, Howes N, Perschl A, Hyman R: Hyaluronan binding function of CD44 is transiently activated on T cells during anin vivo immune response. J Exp Med 180: 383–387, 1994
McBride WH, Bard JBL: Hyaluronidase-sensitive cell halos around adherent cells. Their role in blocking lymphocytemediated cytolysis. J Exp Med 149: 507–515, 1979
Bard JBL, McBride WH, Ross AR: Morphology of hyaluronidase-sensitive cell coats as seen in the SEM after freeze drying. J Cell Sci 62: 371–383, 1983
St John T, Gallatin WM, Idzerda RL: Expression of CD44 confers a new adhesive phenotype on transfected cells. Cell 60: 45–52, 1990
Knudson W, Bartnik E, Knudson CB: Assembly of pericellular matrices by COS-7 cells transfected with CD44 lymphocyte-homing receptor genes. Proc Natl Acad Sci USA 90: 4003–4007, 1993
Laurent T, Fraser J: Hyaluronan. FASEB J 6: 2397–2404, 1992
Kalomiris EL, Bourguignon LYW: Lymphoma protein kinase C is associated with the transmembrane glycoprotein, GP85, and may function in GP85-ankyrin binding. J Biol Chem 264: 8113–8119, 1989
Tsukita S, Oishi K, Sato N, Sagara J, Kawai A, Tsukita S: ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol 126: 391–401, 1994
Cosman D, Lyman SD, Idzerda RL, Beckmann MP, Park LS, Goodwin RG, March CJ: A new cytokine receptor superfamily. Trends Biochem Sci 15: 265–270, 1990
Koch CA, Anderson D, Moran MF, Ellis C, Pawson T: SH2 and SH3 domains: Elements that control interactions of cytoplasmic signaling proteins. Science 252: 668–674, 1991
Taniguchi T, Minami Y: The IL-2/IL-2 receptor system: a current overview. Cell 73: 5–8, 1993
Voss SD, Leary TP, Sondel PM, Robb RJ: Identification of a direct interaction between interleukin 2 and the p64 interleukin 2 receptor γ chain. Proc Natl Acad Sci USA 90: 2428–2432, 1993
Asao H, Takeshita T, Ishii N, Kumaki S, Nakamura M, Sugamura K: Reconstitution of functional interleukin 2 receptor complexes on fibroblastoid cells: Involvement of the cytoplasmic domain of the γ chain in two distinct signaling pathways. Proc Natl Acad Sci USA 90: 4127–4131, 1993
Kirken RA, Rui H, Malabarba MG, Farrar WL: Identification of interleukin-2 receptor associated tyrosine kinase p116 as novel leukocyte-specific Janus kinase. J Biol Chem 269: 19136–19141, 1994
Asao H, Tanaka N, Ishii N, Higuchi M, Takeshita T, Nakamura M, Shirasawa T, Sugamura K: Interleukin 2-induced activation of JAK3: possible involvement in signal transduction for c-myc induction and cell proliferation. FEBS Lett 351: 201–206, 1994
Kawahara A, Minami Y, Taniguchi T: Evidence for a critical role for the cytoplasmic region of the interleukin 2 (IL-2) receptor gamma chain in IL-2, IL-4 and IL-7 signalling. Mol Cell Biol 14: 5433–5440, 1994
Minami Y, Taniguchi T: IL-2 signaling: recruitment and activation of multiple protein tyrosine kinases by the components of the IL-2 receptor. Curr Opin Cell Biol 7: 156–162, 1995
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chiu, R.K., Droll, A., Cooper, D.L. et al. Molecular mechanisms regulating the hyaluronan binding activity of the adhesion protein CD44. J Neuro-Oncol 26, 231–239 (1995). https://doi.org/10.1007/BF01052626
Issue Date:
DOI: https://doi.org/10.1007/BF01052626